Compounds > 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine
Page last updated: 2024-09-05

4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine and glycine

4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine has been researched along with glycine in 2 studies

Compound Research Comparison

Studies
(4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine)		Trials
(4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine)		Recent Studies (post-2010)
(4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine)		Studies
(glycine)		Trials
(glycine)		Recent Studies (post-2010) (glycine)
90135,1637568,415

Protein Interaction Comparison

ProteinTaxonomy4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine (IC50)glycine (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.4852
Sodium- and chloride-dependent glycine transporter 1Homo sapiens (human)106
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.3253
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.3253
Sodium- and chloride-dependent glycine transporter 2Homo sapiens (human)128

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergh, JJ; Castagnoli, N; Mienie, LJ; Pond, SM; Steyn, SJ; Van der Schyf, CJ; Van Staden, E1
Bergh, JJ; Bloomquist, JR; Castagnoli, N; Mienie, LJ; Steyn, SJ; Van der Schyf, CJ1

Other Studies

2 other study(ies) available for 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine and glycine

ArticleYear
Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
    Life sciences, 1997, Volume: 61, Issue:3

    Topics: Animals; Dicarboxylic Acids; Electron-Transferring Flavoproteins; Fatty Acid Desaturases; Flavoproteins; Glutarates; Glycine; Haloperidol; Humans; Iron-Sulfur Proteins; Kinetics; Male; Mitochondria; Multienzyme Complexes; Oxidoreductases Acting on CH-NH Group Donors; Oxygen Consumption; Papio

1997
p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
    Life sciences, 1999, Volume: 65, Issue:5

    Topics: Animals; Antipsychotic Agents; Dopamine; Glycine; Haloperidol; Humans; Male; Mice; Oxidation-Reduction; Papio; Propionates

1999